Bone Biologics - Warrants (13/10/2026) Operating Income

As of the most recent data (June 2026), BBLGW shows a operating income of $-3.1M. That compares with $-4.3M in the prior-year period — up 28.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BBLGW's operating income is now $-3.1M (was $-4.3M) — a 28.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Bone Biologics - Warrants (13/10/2026) is outperforming or lagging.

Tracking BBLGW's operating income over time shows whether Bone Biologics - Warrants (13/10/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $-3.1M That compares with $-4.3M in the prior-year period — up 28.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Bone Biologics - Warrants (13/10/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-3.1M) with ownership activity and broader fundamentals.